Condition: Zellweger Spectrum Disorder · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. define what tests best monitor the progression of the retinal degeneration 3. generate prognostic information about vision loss in ZSD. At each yearly visit, the participants will answer a functional vision questionnaire, have a physical evaluation, blood test, and participate in a variety of vision tests. The investigators will also collect pertinent medical history. Participants will travel to study site. The study will provide financial support for board and travel.
This description comes directly from the study's public registry record.
Nancy E Braverman, MD, MS · 514-934-1934 · nancy.braverman@mcgill.ca
Frederique Arnaud, BScN · 514-934-1934 · frederique.arnaud@muhc.mcgill.ca
Always discuss trial participation with your own doctor first.
| University of Rochester Medical Center/Flaum Eye Institute | Rochester, New York, United States | Recruiting |
| Eye Institute of Alberta | Edmonton, Alberta, Canada | Recruiting |
| Research Institute-McGill University Health Center | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06190626